| Ytd | -83.00% | |
| 1y | -79.34% |
| Open | 1.45 | Prev Close | 1.43 | Low | 1.43 | High | 1.45 | Mkt Cap | 3.15M |
| Vol | 7.98K | Avg Vol | 3.89M | EPS | -1.58 | P/E | -0.91 | Forward P/E | N/A |
| Beta | 0.95 | Short Ratio | 0.65 | Inst. Own | 12.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.74 | 200-d Avg | 3.82 | 1yr Est | 17.33 |
MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.90) per share which missed the analyst consen
All Active Patients Successfully Reached Highest Planned Dose Levels of 48 mg and 64 mg in Ongoing P
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial